There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 520-18-3 | MDL No. : | MFCD00016938 |
Formula : | C15H10O6 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | IYRMWMYZSQPJKC-UHFFFAOYSA-N |
M.W : | 286.24 | Pubchem ID : | 5280863 |
Synonyms : |
Kempferol;Robigenin;Pelargidenolon;Indigo Yellow;Campherol;3,4',5,7-Tetrahydroxyflavone;Trifolitin;Swartziol;Rhamnolutein;Pelargidenon;NSC 656277;Nimbecetin;NSC 407289
|
Chemical Name : | 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one |
Signal Word: | Danger | Class: | 6.1 |
Precautionary Statements: | P281-P301+P310 | UN#: | 2811 |
Hazard Statements: | H301-H341 | Packing Group: | Ⅲ |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetone at 20℃; for 1h; | Semi-synthesis of flavones 8-10 from kaempferol Flavones 8-10 were obtained as previously reported [29]. Compound 8 was obtained by methylation of kaempferol (100 mg) (Sigma-Aldrich, France), using 4 equiv. of dimethyl sulfate (Me2SO4) and 2equiv. of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). The reaction wasperformed at room temperature in dried acetone for 1 h. After precipitation and washing with iced water, obtained residues were solubilized with ethyl acetate (15 mL) and treated with a solution of 1 NHCl (3 mL). Finally, reaction product was extracted with ethyl acetate(3 x 10 mL) and the organic phase was washed with a saturated solution of NaCl, then dried over Na2SO4. Paper filtration and solvent evaporation provided a mixture, which was purified by silica gel column chromatography using as eluent dichloromethane/methanol (95/5, v/v, yield: 70%). For preparation of compounds 9 and 10, kaempferol (80mg, 0.28mmol) was acetylated using acetic anhydride in dry pyridine. The reaction was performed by stirring for 15min at room temperature. After precipitation and washing with iced water, recrystallization in CH2Cl2/CH3OH (9/1, v/v) provided 108mg (0.26mmol) of triacetyl derivative 9 (yield: 95%). The same procedure for the semi-synthesis of 9 was applied for 4h instead of 15min. After precipitation and washing with iced water, recrystallization in CH2Cl2/CH3OH (9/1, v/v) provided 120mg (0.26mmol) of tetra acetyl derivative 10 (yield: 95%). 1H and 13C NMR data of 8-10 were in accordance with those previously reported [29,30]. |
With potassium hydroxide | ||
With potassium carbonate; acetone |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With pyridine at 20℃; for 4h; | Semi-synthesis of flavones 8-10 from kaempferol General procedure: Flavones 8-10 were obtained as previously reported [29]. Compound 8 was obtained by methylation of kaempferol (100 mg) (Sigma-Aldrich, France), using 4 equiv. of dimethyl sulfate (Me2SO4) and 2equiv. of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). The reaction wasperformed at room temperature in dried acetone for 1 h. After precipitation and washing with iced water, obtained residues were solubilized with ethyl acetate (15 mL) and treated with a solution of 1 NHCl (3 mL). Finally, reaction product was extracted with ethyl acetate(3 x 10 mL) and the organic phase was washed with a saturated solution of NaCl, then dried over Na2SO4. Paper filtration and solvent evaporation provided a mixture, which was purified by silica gel column chromatography using as eluent dichloromethane/methanol (95/5, v/v, yield: 70%). For preparation of compounds 9 and 10, kaempferol (80mg, 0.28mmol) was acetylated using acetic anhydride in dry pyridine. The reaction was performed by stirring for 15min at room temperature. After precipitation and washing with iced water, recrystallization in CH2Cl2/CH3OH (9/1, v/v) provided 108mg (0.26mmol) of triacetyl derivative 9 (yield: 95%). The same procedure for the semi-synthesis of 9 was applied for 4h instead of 15min. After precipitation and washing with iced water, recrystallization in CH2Cl2/CH3OH (9/1, v/v) provided 120mg (0.26mmol) of tetra acetyl derivative 10 (yield: 95%). 1H and 13C NMR data of 8-10 were in accordance with those previously reported [29,30]. |
94% | With pyridine at 20℃; | 3,4′,5,7-Tetra-O-acetylkaempferol(1) Aceticanhydride(60 mL)was added to the solution of dry kaempferol (4 g, 13.99 mmol)in pyridine(30 mL), and the mixture was allowed to standovernight at ambienttemperature. After complete conversionmonitored by TLC, the solvent was removedand the residue was poured into crushed ice with vigorous stirring. Theabundant resulting off-white precipitate was recovered by filtration and washedwith cold water and then methanol, and dried in air.The crude product wascrystallized from acetone/95% ethanol (1:3) to afford 1 (5.95 g, 94%) ascolorless needles, mp:183-184C. IR (cm-1): 1775, 1661, 1631, 1503, 1476, 1435, 1370,1186, 1158, 1122,1081, 1013.1H NMR (600 MHz, CDCl3): δ = 7.84 (d, J= 8.7 Hz, 2H), 7.32 (d, J= 2.1Hz, 1H), 7.26 (d, J= 8.7 Hz, 2H), 6.87 (d, J= 2.1 Hz, 1H), 2.43(s, 3H), 2.34 (s, 6H), 2.32 (s, 3H). 13CNMR (150 MHz, CDCl3): δ = 170.24, 169.39, 168.99,167.98, 167.91, 157.10, 154.91, 154.38, 153.08, 150.61, 134.08, 129.76, 127.16,122.21, 114.97, 113.97, 109.10, 21.30,21.18, 20.71. ESI-HRMS: 477.0807 [M+Na]+(calcd. for C23H18O10Na: 477.0792). |
94% | With pyridine |
90% | With pyridine at 20℃; | |
65% | With pyridine at 15℃; for 12h; Inert atmosphere; | 169 Example 169: [4-(3,5,7-triacetoxy-4-oxo-chromen-2-yl)phenyl] acetate To a mixture of 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one (2 g) in pyridine (15 mL) was added acetyl acetate (30 g), and then the mixture was stirred at 15 °C for 12 hr under N2 atmosphere.The solvent was removed under reduced pressure and the residue was poured into crushed ice with vigorous stirring. The solid precipidate was collected by filtration and washed with cold water and then with methanol. The desired compound [4-(3,5,7-triacetoxy-4-oxo-chromen-2-yl)phenyl] acetate (2.1 g, 65% yield) was obtained as a white solid. LCMS: 455.0 (M÷H÷) 1H NMR (400 MHz, CDCI3): O 7.858 (d, 2H), 7.339 (d, 1H), 7.278 7.257 (m, 2H), 6.883 (d, 1H), 2.447 (s, 3H), 2.357 (s, 6H), 2.333 (s, 3H) ppm |
65% | With pyridine at 15℃; for 12h; Inert atmosphere; | 1 Compound 8: [4-(3,5,7-triacetoxy-4-oxo-chromen-2-yl)phenyl] acetate To a mixture of 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one (2 g) in pyridine (15 ml_) was added acetyl acetate (30 g), and then the mixture was stirred at 15 °C for 12 hr under N2 atmosphere. The solvent was removed under reduced pressure and the residue was poured into crushed ice with vigorous stirring. The solid precipitate was collected by filtration and washed with cold water and then with methanol. Compound 8 (2.1 g, 65% yield) was obtained as a white solid. LCMS: 455.0 (M+H+) 1 H NMR (400 MHz, CDCI3) 7.858 (d, 2H), 7.339 (d, 1 H), 7.278 7.257 (m, 2H), 6.883 (d, 1 H), 2.447 (s, 3H), 2.357 (s, 6H), 2.333 (s, 3H) |
65% | With pyridine at 15℃; for 12h; Inert atmosphere; | 1 Compound 20: [4-(3,5,7-triacetoxy-4-oxo-chromen-2-yl)phenyl] acetate To a mixture of 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one (2 g) in pyridine (15 mL) was added acetyl acetate (30 g), and then the mixture was stirred at 15 °C for 12 hr under N atmosphere. The solvent was removed under reduced pressure and the residue was poured into crushed ice with vigorous stirring. The solid precipitate was collected by filtration and washed with cold water and then with methanol. Compound 20 (2.1 g,65% yield) was obtained as a white solid. LCMS: 455.0 (M+H+) 1 H (0797) NMR (400 MHz, CDCIs) d 7.858 (d, 2H), 7.339 (d,1 H), 7.278 7.257 (m, 2H),6.883 (d,1 H), 2.447 (s,3H), 2.357 (s,6H), 2.333 (s,3H) |
65% | With pyridine at 15℃; for 12h; Inert atmosphere; | Compound 8: [4-(3,5,7-triacetoxy-4-oxo-chromen-2-yl)phenyl]acetate To a mixture of 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one (2 g) in pyridine (15 ml_) was added acetyl acetate (30 g), and then the mixture was stirred at 15 C for 12 hr under N2 atmosphere. The solvent was removed under reduced pressure and the residue was poured into crushed ice with vigorous stirring. The solid precipidate was collected by filtration and washed with cold water and then with methanol. Compound 8 (2.1 g, 65% yield) was obtained as a white solid. LCMS: 455.0 (M+H+) 1H NMR (400 MHz, CDC ) 7.858 (d, 2H), 7.339 (d, 1H), 7.278 7.257 (m, 2H), 6.883 (d, 1H), 2.447 (S,3H), 2.357 (s, 6H), 2.333 (S,3H) |
With pyridine | ||
15 mg | With dmap In pyridine Ambient temperature; | |
With pyridine at 20℃; | ||
15 mg | With pyridine; dmap at 20℃; | |
With pyridine at 20℃; | ||
With triethylamine In dichloromethane for 1h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With potassium carbonate In acetone at 50℃; for 48h; | 1.1 1. Preparation of compound a1 Accurately weigh kaempferol (20.00mmol, 6.00g) and dissolve it in 5mL acetone, add K2CO3 (160.00mmol, 23.20g), stir at 50°C and add dimethyl sulfate (100.00mmol, 9.94mL) dropwise.After 48h, TLC monitors the reaction progress. After the reaction is over, add an appropriate amount of dilute sodium hydroxide solution to quench the reaction, and adjust the pH to neutral with dilute hydrochloric acid.Concentrate the reaction solution, add distilled water and shake well, extract 3 times with ethyl acetate, dry with anhydrous sodium sulfate, filter and concentrate to obtain a crude product. The crude product was separated and purified by gel column chromatography to obtain a1 (6.12 g, yield 90.0%) as a yellow solid. |
90% | With potassium carbonate In acetone at 50℃; | |
86.3% | With potassium carbonate In acetone at 50℃; for 48h; | 1 Example 1: Preparation method of Compound 1 Weighing naphthol (0.7mmol, 200mg)And anhydrous potassium carbonate (5 mmol, 691.05 mg) in a reaction flask, adding 9 mL of acetone,Stir at 50 ° C and add dimethyl sulfate (5 mmol, 379 μL).TLC was monitored (DCM: MeOH = 30:1). After 48h treatment.The reaction was quenched by adding an appropriate amount of dilute sodium hydroxide solution (removing the toxic dimethyl sulfate), and the pH was adjusted to neutral with dilute hydrochloric acid.The reaction mixture was concentrated, washed with EtOAc EtOAc EtOAc.The crude product was purified by gel column chromatography to yield yellow solid. The yield was 86.3%. |
With potassium carbonate | ||
With potassium carbonate In acetone for 4h; Heating; | ||
With potassium hydroxide In water; acetone |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; water for 0.75h; Reflux; | ||
With hydrogenchloride In water at 100℃; for 0.5h; | Sugar and aglycone analysis General procedure: Acid hydrolysis of flavonoids was carried out in 2M HCl, at 100°C for 30min. After cooling, HCl was removed by evaporation and the hydolysate was dried under a stream of N2. Aglycones formed by acid hydrolysis were analyzed by LC-MS as described above using commercially available standards. Sugars released by hydrolysis were analyzed by a glucose assay kit and a galactose assay kit according to the manufactures procedures to determine their absolute configuration. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane at 20℃; for 0.25h; | |
81% | In N,N-dimethyl-formamide at 20℃; Inert atmosphere; | 1.2 Step 2: Preparation of 3,7,4'-tri-O- t-butyldimethylsilyl kaempferol Under nitrogen, the kaempferol (2g, 7mmol) and TBSCl (4.2g, 28mmol) was dissolvedDry DMF (5mL), and room temperature, TLC track to complete the reaction. The reaction systemExtracted with DCM, washed with water, then washed with a saturated brine, dried over anhydrous sodium sulfate.The resulting filtrate was concentrated under reduced pressure column chromatography to obtain the objective product (3.6g, 81%); |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | With palladium 10% on activated carbon; hydrogen In tetrahydrofuran; methanol for 12h; | |
58% | With hydrogen; palladium(II) hydroxide In tetrahydrofuran; methanol at 20℃; for 3h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | With potassium metabisulphite In ethanol at 100℃; | (d) Flavonols 6, 6a, 6b, 6c and 6d General procedure: Dihydroflavonols (5, 0.3 mmol) in ethanol (2.5 ml) was added to potassium metabisulphite, (5.0 ml, 20%) and heated at 100 °C (5-8 h). The reaction mixture is poured into crushed ice. The centrifuged product was purified by column (SiO2) chromatography. The purity of final products were analyzed by HPLC and NMR (Supplementary data). |
23.4 g | With oxygen; potassium carbonate In ethanol for 8h; Reflux; | 4.3 3) Preparation of kaempferol oxide 36.3 g of crude dihydrokaempferol obtained in step 2.3) was put into a reaction bottle.Add 185ml of 70% ethanol,Stir well,Add 6.8 g of anhydrous potassium carbonate,Passing oxygen,Then heated to reflux,Oxidation reaction,High performance liquid chromatography,The kaempferol is no longer increased as the end point of the reaction control.The reaction was completed after about 8 hours.Drop to room temperature and leave overnight.filter,Obtained a yellow solid,Add 180g of water,Filtered after 2 hours of reflux,The filter cake is washed and dried,Obtained 23.4g of kaempferol,The content is 98% (HPLC). |
With FLAVONOL SYNTHASE Enzymatic reaction; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
18.5% | Stage #1: kaempferol With potassium carbonate In 1,4-dioxane for 1.5h; Reflux; Stage #2: C10H9BrO2 In 1,4-dioxane Reflux; Stage #3: With hydrogenchloride In water | 7.2. General procedure for the synthesis of compounds 3 General procedure: To a mixture of kaempferol (1.2 eq) and K2CO3 (1.2 eq) in 1,4-dioxane (10 ml), which was stirred for 90 min while maintaining gentle reflux, was added a solution of the 2 compounds (1 eq) in 1,4-dioxane (5 ml) for 30 min. The reaction mixture was refluxed until the starting material disappeared, as indicated by TLC (CH2Cl2:MeOH, 95:5). The solvent was removed from the reaction mixture under reduced pressure. Water was added, the aqueous phase was neutralized (to pH 7) with 1 M HCl, and then extracted with ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered and concentrated. The crude product was purified using a gel-permeation chromatograph (HW-40; CH2Cl2:MeOH, 1:1) and prepared-TLC to give a yellow solid product. |
Stage #1: kaempferol With potassium carbonate In 1,4-dioxane for 1.5h; Reflux; Stage #2: C10H9BrO2 In 1,4-dioxane Reflux; | 3.1 Example 3 General Procedure for the Synthesis of Compounds General procedure: To a mixture of kaempferol (1.2 eq) and K2CO3 (1.2 eq) in 1,4-dioxane (10 ml), which was stirred for 90 minutes while maintaining gentle reflux, was added a solution of the compound III (1 eq) in 1,4-dioxane (2 nil) for 30 minutes. The reaction mixture was refluxed until the starting material disappeared, as indicated by TLC. The solvent was removed from the reaction mixture under reduced pressure. Water was added, the aqueous phase was neutralized (to pH 7) with 1 M HCl, and then extracted with ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered and concentrated. The crude product was purified using a gel-permeation chromatograph (HW-40; CH2Cl2-MeOH, 1:1) and preparation-TLC to give compound series I as shown in Formula (6). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 15h; Inert atmosphere; | 3,5,7-Trimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one General procedure: To a stirred solution of kaempferol (286 mg, 1.0mmol) in dry DMF (5 mL) was added K2CO3 (829 mg, 6.0mmol) and CH3I (851 mg, 6 mmol). After the addition, the mixture wasstirred for 15 h at room temperature. The reaction mixture was then dilutedwith CH2Cl2 (20 mL) and poured into aqueous HCl (0.1 M)(10 mL). The organic layer was separated, washed with H2O (3×10 mL)and dried over Mg2SO4. After concentrated to drynessunder reduced pressure, the crude product was purified by column chromatographyon silica (petroleum ether/ethyl acetate 1:1) to afford the known compound 247 (266 mg, 78%) as a white solid |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With sodium carbonate In N,N-dimethyl-formamide at 20℃; for 15h; Inert atmosphere; | 5-Hydroxy-3,4',7-trimethoxyflavone (18) To a stirred solution of kaempferol (286 mg, 1.0mmol) in dry DMF (5 mL) was added Na2CO3 (477 mg, 4.5mmol) and CH3I (639 mg, 4.5 mmol). After the addition, the mixturewas stirred for 15 h at room temperature. The reaction mixture was then dilutedwith CH2Cl2 (20 mL) and poured into aqueous HCl (0.1 M)(10 mL). The organic layer was separated, washed with H2O (3×10 mL)and dried over Mg2SO4. After concentrated to drynessunder reduced pressure, the crude product was purified by column chromatographyon silica (petroleum ether/ethyl acetate 3:1) to afford the known compound 184 (181 mg, 55%) as a yellow solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride In water at 100℃; for 0.5h; | Sugar and aglycone analysis General procedure: Acid hydrolysis of flavonoids was carried out in 2M HCl, at 100°C for 30min. After cooling, HCl was removed by evaporation and the hydolysate was dried under a stream of N2. Aglycones formed by acid hydrolysis were analyzed by LC-MS as described above using commercially available standards. Sugars released by hydrolysis were analyzed by a glucose assay kit and a galactose assay kit according to the manufactures procedures to determine their absolute configuration. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: kaempferol 3-O-[(6-O-E-p-coumaroyl)-β-D-glucopyranosyl(1→2)]-α-L-rhamnopyranosyl(1→6)}-β-D-galactopyranoside-7-O-α-L-rhamnopyranoside With sodium hydroxide; ascorbic acid at 20℃; for 2h; Darkness; Stage #2: With hydrogenchloride; water In methanol at 100℃; for 2h; | 3.7. Alkaline and Acid Hydrolysis of Flavonoids The water phases were dried and then desalted by SPE (Oasis HLB 30 mg). Methanol SPE eluates,containing deacylated flavonoids, were dried and subjected to acid hydrolysis (1 mL of 2M HCl, 2 h,100 °C). Aglycones were then extracted with ethyl acetate (3 × 1 mL), dried with a stream of nitrogen,dissolved in 50% methanol, and identified by UPLC-ESI-MS. Chromatographic separations wereperformed on a ACQUITY BEH C18 (100 × 2.1 mm, 1.7 μm; Waters) column (40 °C). The mobile phases were water with 0.1% FA (A) and in acetonitrile with 0.1% FA (B). Samples were separated (400 μL·min-1) with the following gradient: 0-1 min, 15% B; 1-11 min, 15%-95% B; 11-13 min, 95%B; 13-13.1 min, 95%-15% B; 13.1-15 min, 15% B. Mass spectra were obtained in negative ionization mode, MS parameters were as follows: capillary voltage 2.8 kV; cone voltage 45 V; source temperature 140 °C, desolvation temperature 350 °C, cone gas flow (nitrogen) 100 L·h-1 desolvation gas flow 800 L·h-1.Sugar-containing aqueous layers were neutralized with Amberlite IRA-400 (OH- form) [33]. After drying, the samples were used to determine the absolute configuration of the constituent monosaccharides. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: kaempferol 3-O-[(6-O-E-caffeoyl)-β-D-glucopyranosyl(1→2)]-β-D-galactopyranoside-7-O-(2-O-E-caffeoyl')-β-D-glucuropyranoside With sodium hydroxide; ascorbic acid at 20℃; for 2h; Darkness; Stage #2: With hydrogenchloride; water In methanol at 100℃; for 2h; | 3.7. Alkaline and Acid Hydrolysis of Flavonoids The water phases were dried and then desalted by SPE (Oasis HLB 30 mg). Methanol SPE eluates,containing deacylated flavonoids, were dried and subjected to acid hydrolysis (1 mL of 2M HCl, 2 h,100 °C). Aglycones were then extracted with ethyl acetate (3 × 1 mL), dried with a stream of nitrogen,dissolved in 50% methanol, and identified by UPLC-ESI-MS. Chromatographic separations wereperformed on a ACQUITY BEH C18 (100 × 2.1 mm, 1.7 μm; Waters) column (40 °C). The mobile phases were water with 0.1% FA (A) and in acetonitrile with 0.1% FA (B). Samples were separated (400 μL·min-1) with the following gradient: 0-1 min, 15% B; 1-11 min, 15%-95% B; 11-13 min, 95%B; 13-13.1 min, 95%-15% B; 13.1-15 min, 15% B. Mass spectra were obtained in negative ionization mode, MS parameters were as follows: capillary voltage 2.8 kV; cone voltage 45 V; source temperature 140 °C, desolvation temperature 350 °C, cone gas flow (nitrogen) 100 L·h-1 desolvation gas flow 800 L·h-1.Sugar-containing aqueous layers were neutralized with Amberlite IRA-400 (OH- form) [33]. After drying, the samples were used to determine the absolute configuration of the constituent monosaccharides. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: kaempferol 3-O-β-D-glucopyranosyl(1→2)-β-D-galactopyranoside-7-O-β-D-glucuropyranoside With sodium hydroxide; ascorbic acid at 20℃; for 2h; Darkness; Stage #2: With hydrogenchloride; water In methanol at 100℃; for 2h; | 3.7. Alkaline and Acid Hydrolysis of Flavonoids The water phases were dried and then desalted by SPE (Oasis HLB 30 mg). Methanol SPE eluates,containing deacylated flavonoids, were dried and subjected to acid hydrolysis (1 mL of 2M HCl, 2 h,100 °C). Aglycones were then extracted with ethyl acetate (3 × 1 mL), dried with a stream of nitrogen,dissolved in 50% methanol, and identified by UPLC-ESI-MS. Chromatographic separations wereperformed on a ACQUITY BEH C18 (100 × 2.1 mm, 1.7 μm; Waters) column (40 °C). The mobile phases were water with 0.1% FA (A) and in acetonitrile with 0.1% FA (B). Samples were separated (400 μL·min-1) with the following gradient: 0-1 min, 15% B; 1-11 min, 15%-95% B; 11-13 min, 95%B; 13-13.1 min, 95%-15% B; 13.1-15 min, 15% B. Mass spectra were obtained in negative ionization mode, MS parameters were as follows: capillary voltage 2.8 kV; cone voltage 45 V; source temperature 140 °C, desolvation temperature 350 °C, cone gas flow (nitrogen) 100 L·h-1 desolvation gas flow 800 L·h-1.Sugar-containing aqueous layers were neutralized with Amberlite IRA-400 (OH- form) [33]. After drying, the samples were used to determine the absolute configuration of the constituent monosaccharides. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: kaempferol 3-O-[(6-O-E-caffeoyl)-β-D-glucopyranosyl-(1→2)]-β-D-galactopyranoside-7-O-β-D-glucuropyranoside With sodium hydroxide; ascorbic acid at 20℃; for 2h; Darkness; Stage #2: With hydrogenchloride; water In methanol at 100℃; for 2h; | 3.7. Alkaline and Acid Hydrolysis of Flavonoids The water phases were dried and then desalted by SPE (Oasis HLB 30 mg). Methanol SPE eluates,containing deacylated flavonoids, were dried and subjected to acid hydrolysis (1 mL of 2M HCl, 2 h,100 °C). Aglycones were then extracted with ethyl acetate (3 × 1 mL), dried with a stream of nitrogen,dissolved in 50% methanol, and identified by UPLC-ESI-MS. Chromatographic separations wereperformed on a ACQUITY BEH C18 (100 × 2.1 mm, 1.7 μm; Waters) column (40 °C). The mobile phases were water with 0.1% FA (A) and in acetonitrile with 0.1% FA (B). Samples were separated (400 μL·min-1) with the following gradient: 0-1 min, 15% B; 1-11 min, 15%-95% B; 11-13 min, 95%B; 13-13.1 min, 95%-15% B; 13.1-15 min, 15% B. Mass spectra were obtained in negative ionization mode, MS parameters were as follows: capillary voltage 2.8 kV; cone voltage 45 V; source temperature 140 °C, desolvation temperature 350 °C, cone gas flow (nitrogen) 100 L·h-1 desolvation gas flow 800 L·h-1.Sugar-containing aqueous layers were neutralized with Amberlite IRA-400 (OH- form) [33]. After drying, the samples were used to determine the absolute configuration of the constituent monosaccharides. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: kaempferol 3-O-[(6-O-E-p-coumaroyl)-β-D-glucopyranosyl-(1→2)]-β-D-galactopyranoside-7-O-β-D-glucuropyranoside With sodium hydroxide; ascorbic acid at 20℃; for 2h; Darkness; Stage #2: With hydrogenchloride; water In methanol at 100℃; for 2h; | 3.7. Alkaline and Acid Hydrolysis of Flavonoids The water phases were dried and then desalted by SPE (Oasis HLB 30 mg). Methanol SPE eluates,containing deacylated flavonoids, were dried and subjected to acid hydrolysis (1 mL of 2M HCl, 2 h,100 °C). Aglycones were then extracted with ethyl acetate (3 × 1 mL), dried with a stream of nitrogen,dissolved in 50% methanol, and identified by UPLC-ESI-MS. Chromatographic separations wereperformed on a ACQUITY BEH C18 (100 × 2.1 mm, 1.7 μm; Waters) column (40 °C). The mobile phases were water with 0.1% FA (A) and in acetonitrile with 0.1% FA (B). Samples were separated (400 μL·min-1) with the following gradient: 0-1 min, 15% B; 1-11 min, 15%-95% B; 11-13 min, 95%B; 13-13.1 min, 95%-15% B; 13.1-15 min, 15% B. Mass spectra were obtained in negative ionization mode, MS parameters were as follows: capillary voltage 2.8 kV; cone voltage 45 V; source temperature 140 °C, desolvation temperature 350 °C, cone gas flow (nitrogen) 100 L·h-1 desolvation gas flow 800 L·h-1.Sugar-containing aqueous layers were neutralized with Amberlite IRA-400 (OH- form) [33]. After drying, the samples were used to determine the absolute configuration of the constituent monosaccharides. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: kaempferol 3-O-[(6-O-E-feruloyl)-β-D-glucopyranosyl-(1→2)]-β-D-galactopyranoside-7-O-β-D-glucuropyranoside With sodium hydroxide; ascorbic acid at 20℃; for 2h; Darkness; Stage #2: With hydrogenchloride; water In methanol at 100℃; for 2h; | 3.7. Alkaline and Acid Hydrolysis of Flavonoids The water phases were dried and then desalted by SPE (Oasis HLB 30 mg). Methanol SPE eluates,containing deacylated flavonoids, were dried and subjected to acid hydrolysis (1 mL of 2M HCl, 2 h,100 °C). Aglycones were then extracted with ethyl acetate (3 × 1 mL), dried with a stream of nitrogen,dissolved in 50% methanol, and identified by UPLC-ESI-MS. Chromatographic separations wereperformed on a ACQUITY BEH C18 (100 × 2.1 mm, 1.7 μm; Waters) column (40 °C). The mobile phases were water with 0.1% FA (A) and in acetonitrile with 0.1% FA (B). Samples were separated (400 μL·min-1) with the following gradient: 0-1 min, 15% B; 1-11 min, 15%-95% B; 11-13 min, 95%B; 13-13.1 min, 95%-15% B; 13.1-15 min, 15% B. Mass spectra were obtained in negative ionization mode, MS parameters were as follows: capillary voltage 2.8 kV; cone voltage 45 V; source temperature 140 °C, desolvation temperature 350 °C, cone gas flow (nitrogen) 100 L·h-1 desolvation gas flow 800 L·h-1.Sugar-containing aqueous layers were neutralized with Amberlite IRA-400 (OH- form) [33]. After drying, the samples were used to determine the absolute configuration of the constituent monosaccharides. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With glycosyltransferase from Carthamus tinctorius (L.) (Honghua) recombinant In dimethyl sulfoxide at 30℃; for 12h; Enzymatic reaction; | |
With flavonoid 7-O-glucosyltransferase from Andrographis paniculata In methanol at 30℃; for 12h; Enzymatic reaction; | 3.5. Enzyme assay and product identification General procedure: All assays and incubations were performed in 100 ll of 50mM Tris-HCl (pH 8.0)containing 8 lg of purified proteins, 200 lM aglycone, and 3200 lM UDP-glucose.The reactions were incubated at 30 C for 12 h and terminated by the addition of200 ll of methanol. The products of the reactions were filtered through a 0.22-lmnylon syringe filter and analyzed using a Waters Acquity UPLC-I-Class system(Waters Corp., Milford, MA) with an Acquity UPLC BEH C18 column (1.7 mm,2.1mm 50 mm). The column temperature was set to 40 C, and the flow rate was400 lL/min. Mobile phase A was a 0.1% formic acid aqueous solution, and mobilephase B was acetonitrile. Gradient programs were used to analyze the reaction mixtures(Table 1). The total conversion rate was calculated to be one percent of the sumof the peak areas of the substrate and product(s). The experiment was performed inthe ESI (-) mode as previously described [17]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | With triethylamine In acetone at 0 - 20℃; for 3h; | |
61% | With triethylamine In acetone at 20℃; Inert atmosphere; | 3.2 Step 2:3,7,4'- tri -O- hexanoyl kaempferolPreparation Under nitrogen, the kaempferol (2.3g, 8mmol) and hexanoyl chloride (3.7ml, 26.4mmol) was dissolved in dry acetone (100mL), and then added triethylamine (3.65ml, 26.4mmol). Reaction at room temperature, TLC track to complete the reaction. After the reaction system was concentrated under reduced pressure column chromatography to obtain the objective product (2.8g, 61%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With potassium carbonate In acetone | |
72% | With potassium carbonate In N,N-dimethyl-formamide at 20℃; Inert atmosphere; | 2.2 Step 2:3,7,4'- three -O- benzyl kaempferolPreparation Under nitrogen, the kaempferol (4.2g, 15mmol) and benzyl bromide (5.7ml, 48mmol) was dissolved in dry DMF (20mL), and then potassium carbonate powder (7.3g, 53mmol). Reaction at room temperature, TLC track to complete the reaction. The reaction system was extracted with DCM, washed with water, then washed with a saturated brine, dried over anhydrous sodium sulfate. The resulting filtrate was concentrated under reduced pressure column chromatography to obtain the objective product (6g, 72%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride In methanol; water at 80℃; for 2h; | Acid hydrolysis of compound 2 Three mg of compound 2 was hydrolyzed with 10% HCl (3.5 ml) in aqueous methanol at 80°C for 2 hour, after the removal of the solvent the reaction mixture was diluted by distilled water,whereby it give aglycone and sugar, the aglycone was identified via CO-PC with authentic sample and sugar moieties were detected via CO-TLC with authentic sugar markers in system(CHCl3:Me2CO:MeOH:H2O, 3:3:3:1 and CH2Cl2:MeOH:H2O, 6:9:1) respectively. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
43% | Stage #1: kaempferol With triethylamine In methanol Stage #2: tetrakis(dimethylsulfoxide)dichlororuthenium(II) In methanol at 20℃; for 10h; Darkness; | Synthesis of Complex 1. A kaem methanolic solution was prepared by dissolving kaem (286 mg, 1.00 mmol) into methanol (25 mL) with an equimolar quantity of triethylamine(139 μL, 1.00 mmol). Next, RuCl2(DMSO)4 (484 mg,1.00 mmol) was also dissolved in methanol (25 mL) in aseparate flask. The RuCl2(DMSO)4 solution was then addeddropwise into the prepared kaem solution. The reaction mixture was stirred for 10 h at room temperature; Al foilwas used to protect the reaction mixture from light. Thecolor of the reaction mixture changed from light yellow toreddish brown (Scheme 2). The solvent was removed byrotary evaporation to afford the crude product (~650 mg).Purification of Complex 1. The crude product was dissolvedin methylene chloride (MC) and loaded onto asilica-packed column. The column was eluted using a 10%methanol/MC solution, and the product was monitored bythin-layer chromatography (TLC). The solvent of the collectedproduct was removed by rotary evaporation followedby drying in a vacuum oven at 80C. The purified samplewas recrystallized from a minimum amount of methanol, ina 4 mL vial. The vial was wrapped with Al foil, with severalholes punctured on the top, to protect the product fromlight. The container was stored in a vibration-free location,at room temperature for 24 h. Dark brown block-shapedmicrocrystals were collected (282 mg, yield: 43%). Elementalanalysis data for RuC22H39ClO14S3 [RuC21H27-ClO9S3 4H2O CH3OH]: Calcd. (%) for RuC22H39ClO14S3: C 34.74, H 5.31, S 12.65; found: C 34.69, H5.06, S 12.76. 1H NMR (methanol-d4) δ (ppm): 8.402 (d,J = 8.50 Hz, 2H, Ar-H), 6.915 (d, J = 8.50 Hz, 2H, Ar-H),6.385 (s, 1H, 8-CH), 6.179 (s, 1H, 6-CH), 2.676 (s,18H, CH3). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With pyridine at 20℃; for 4h; Inert atmosphere; | 4.2.4 Semi-synthesis of flavone 16 80mg (0.28mmol) of commercial kaempferol (11) were acetylated by stirring with acetic anhydride in anhydrous pyridine at room temperature for 4h. The crudes were precipitated and washed in ice water. The resulting was recrystallized in CH2Cl2/ CH3OH (9/1, v/v) to furnish 120mg (0.26mmol) of tetraacetyl derivative 16 (yield: 95%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With pyridine at 20℃; for 0.25h; Inert atmosphere; | 4.2.3 Semi-synthesis of flavone 15 80mg (0.28mmol) of commercial kaempferol (11) were acetylated by stirring with acetic anhydride in dry pyridine at room temperature for 15min. The crudes were precipitated and washed in iced water. The resulting was recrystallized in CH2Cl2/ CH3OH (9/1, v/v) to furnish 108mg (0.26mmol) of triacetyl derivative 15 (yield: 95%). |
95% | With pyridine at 20℃; for 0.25h; | Semi-synthesis of flavones 8-10 from kaempferol General procedure: Flavones 8-10 were obtained as previously reported [29]. Compound 8 was obtained by methylation of kaempferol (100 mg) (Sigma-Aldrich, France), using 4 equiv. of dimethyl sulfate (Me2SO4) and 2equiv. of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). The reaction wasperformed at room temperature in dried acetone for 1 h. After precipitation and washing with iced water, obtained residues were solubilized with ethyl acetate (15 mL) and treated with a solution of 1 NHCl (3 mL). Finally, reaction product was extracted with ethyl acetate(3 x 10 mL) and the organic phase was washed with a saturated solution of NaCl, then dried over Na2SO4. Paper filtration and solvent evaporation provided a mixture, which was purified by silica gel column chromatography using as eluent dichloromethane/methanol (95/5, v/v, yield: 70%). For preparation of compounds 9 and 10, kaempferol (80mg, 0.28mmol) was acetylated using acetic anhydride in dry pyridine. The reaction was performed by stirring for 15min at room temperature. After precipitation and washing with iced water, recrystallization in CH2Cl2/CH3OH (9/1, v/v) provided 108mg (0.26mmol) of triacetyl derivative 9 (yield: 95%). The same procedure for the semi-synthesis of 9 was applied for 4h instead of 15min. After precipitation and washing with iced water, recrystallization in CH2Cl2/CH3OH (9/1, v/v) provided 120mg (0.26mmol) of tetra acetyl derivative 10 (yield: 95%). 1H and 13C NMR data of 8-10 were in accordance with those previously reported [29,30]. |
90.5% | With pyridine at 100 - 140℃; | 2.1 Example 2: Preparation of 6-prenyl substituted apigenin 1) 2 g of apigenin, 3 to 4 equivalents of acetic anhydride, 1 to 2 times of pyridine,The reaction is carried out at 100 to 140 ° C for 2 to 24 hours, the product is IIIa, and the yield is 90.5%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With water In ethanol; acetone at 25℃; for 3h; | KAE·BPY··2H2O Kaempferol (14.3 mg, 0.05 mmol) and 4,40-bipyridine dehydrate (4.8 mg, 0.025 mmol) were combined in8.0 mL ethanol and 2.0 mL acetone with stirring at 25 C for 3 h. The filtrate was evaporated slowly at room temperature; block yellow crystals were obtained after 5 days (Fig. S1a). The resulting products were characterized by single crystal X-ray diffraction, XPRD, IR and NMR. The other two cocrystals were prepared under similar conditions and post-processing except for the molar ration of flavonols and 4,40-bipyridine dehydrate. IR data (KBr cm1): 3693w,3211s, 2974s, 2687 m, 2642 m, 2614 m,1988w,1898w,1761w,1611s,1525 m, 1454 m, 1375 m, 1320 m, 1180s, 1081s, 1017s, 835s, 733w,634 m, 576 m, 477s, 436 m (Fig. S2) [32]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sulfuric acid | ||
With hydrogenchloride In methanol at 80℃; for 4h; | 3.6. Acid Hydrolysis of Compounds 4-8 General procedure: 5 mg of each compound was separately refluxed with 2M HCl in MeOH (5 mL) at80 C for 4 h in a water bath. The reaction mixture was evaporated, and the hydrolysateafter dilution with H2O (10 mL) was extracted with CHCl3 (3 10 mL). The CHCl3 extractswere evaporated to afford the aglycones, which were identified as kampferol for 4 and 7,isorhamnetin for 5, quercetin for 6 and benzyl alcohol for 8 by comparison with authenticsamples, respectively. The aqueous layer was neutralized with sodium carbonate andconcentrated to 1 mL under reduced pressure. The residue was compared with standardsugars by Si gel TLC [(CHCl3-MeOH-H2O:30:12:4), 9 mL of lower layer and 1 mL ofHOAc], which indicated the sugars to be L-rhamnose in compounds 4, 6 and 7 and glucosein compounds 5 and 8. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91.8% | With 4-methylpiperidin at 100 - 140℃; | 3.1 Example 3: Preparation of 8-isoprenyl-substituted apigenin 1) 2 g of apigenin, 3.3 to 5 equivalents of acetic anhydride, 2 to 4 times of 4-methylpiperidine, reacted at 100 to 140 ° C for 4 to 21 h, the product is IIa,The yield was 91.8%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92.4% | With piperidine at 100 - 140℃; | 1.1 Example 1: Preparation of 6,8-diisoprenyl-substituted apigenin 1) 2 g of apigenin, 2-2.4 times equivalent of acetic anhydride, 2-4 times of piperidine,The reaction is carried out at 100 to 140 ° C for 2 to 24 hours, and the product is IIa, and the yield is 92.4% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | With 3-O-glycosyltransferase from Scutellaria baicalensis In dimethyl sulfoxide at 45℃; for 4h; Enzymatic reaction; regiospecific reaction; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
23.6% | With potassium carbonate; triphenylphosphine; bis(dibenzylideneacetone)-palladium(0) In N,N-dimethyl-formamide at 80℃; for 10h; Inert atmosphere; Sealed tube; regioselective reaction; | 2.2.3. General Procedure for the Synthesis of Target Derivatives 3a-3i, 4a-4g, 5a-5e General procedure: Chrysin 2a (127.12 mg, 0.5 mmol), Pd(dba)2 (5.75 mg, 0.01 mmol), K2CO3 (138.21 mg, 1.0 mmol),PPh3 (13.11 mg, 0.05 mmol), allene (112.13 mg, 1.0 mmol), and anhydrous DMF (5 mL) were addedto a 30 mL tube under argon, which was then sealed. The resulting mixture was stirred at 80 °C for12 h. After completion, the reaction solution was cooled down to room temperature before 80 mLwater was added, followed by the addition of 1 N HCl aqueous solution at 0 °C, until the pH value reached 7. Ethyl acetate (100 mL) was added to the reaction solution and the organic layer was washed sequentially with a large amount of water (4 x 200 mL), and then brine, before being dried overanhydrous Na2SO4. The solvent was evaporated under reduced pressure. The crude product was purified by silica gel column chromatography (petroleum ether-ethylacetate, 5:1) to give 3a (78.8 mg,43% yield). Compounds 3b-3i, 4a-4g, and 5a-5e were prepared according to similar procedures in which the double-substitution is a by product. The products 4a-4g were generated in a shorter time compared with the other products (within 10 h). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride In water at 90℃; for 5h; | 2.4 Hydrolysis of 1-3 General procedure: Compounds 1-3 (10mg each) were separately dissolved in 1% aqueous NaHCO3 (10mL) and then heated at 90°C for 6h. To get the flavonoid glycosides which lose the monoterpenyl moiety, the reaction mixture was purified by Flash-ODS after cooling. Then 2mol/L HCl solution (2mL) was added to the sample solution and heated at 90°C for 5h (Fig. 2 ). When cooling, the mixture was neutralized with NaHCO3, and then dried by vacuum concentration to get the sample. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5.8% | With potassium carbonate In 1,4-dioxane at 80℃; for 24h; | 3.1 Example 3: Preparation method of compound W1-W34 General procedure: Weigh 1 equivalent of B1-B34, 2 equivalents of kaempferol, 2 equivalents of anhydrous potassium carbonate In the reaction flask, a 1,4-dioxane dispersion raw material was added, and the reaction liquid was stirred at 80 ° C for 24 hours, and then the reaction was stopped. To the reaction solution, 0.6 mol/L of dilute hydrochloric acid was added to adjust the pH to a weak acidity, and then 10 ml of distilled water was added thereto, and the aqueous phase was extracted three times with ethyl acetate. The organic phase was collected and dried over anhydrous magnesium sulfate. , The crude product was purified by HW-40C gel column chromatography (mobile phase, Purification by thin layer chromatography using dichloromethane:methanol = 2:1) (developing agent, dichloromethane: methanol = 19:1) A pale yellow solid W1-W34 was obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
62% | Stage #1: kaempferol With [D]-sodium hydroxide; platinum on activated charcoal; water-d2 at 130℃; for 9h; Inert atmosphere; Stage #2: With formic acid at 130℃; for 1h; Inert atmosphere; | 31 Example 31 Add 10 mg of kaempferol to 200 μL of heavy water to the reaction vessel.1mg Pt/C and 70μLdeuteriumSodium oxide solution,Filled with nitrogen and reacted at 130 ° C for 9 hours.Then, 70 μL of formic acid was added and reacted at 130 ° C for 1 hour.The reaction solution was collected and lyophilized to obtain a solid, which was dissolved in ethanol.The filtrate was collected by filtration and dried to obtain a deuterated kaempferol solid.Mass spectrometry(deuteriumFour main peaks)The yield was 62%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
4.6% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
2.2% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
12.6% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
6.1% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
9.8% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
2.5% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
2.3% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
4.6% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
2.5% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
3.5% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
6.8% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
9.6% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
12.6% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
10.3% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
4.9% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
2.3% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5.2% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1.8% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
6.8% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
13% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
16.5% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5.8% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. 5.1.3.1 3-O-[(E)-4-(4-ethynyphenyl)-2-oxobut-3-en-1-yl]kaempferol (4a) Yield: 5.8%. 1H NMR (400MHz, DMSO-d6): δ 12.53 (1H, s, OH), 10.87 (1H, s, OH), 10.24 (1H, s, OH), 8.03 (2H, d, J=8.8Hz), 7.68 (2H, d, J=8.0Hz), 7.65 (1H, d, J=16.4Hz), 7.52 (2H, d, J=8.0Hz), 7.07 (1H, d, J=16.4Hz), 6.92(2H, d, J=8.8Hz), 6.47 (1H, d, J=2.0Hz), 6.21 (1H, d, J=2.0Hz), 5.07 (2H, s), 4.36 (1H, s). 13C NMR (100MHz, DMSO-d6): δ 194.5, 177.4, 164.2, 161.1, 160.2, 156.3, 155.2, 141.4, 136.2, 134.6, 132.2, 130.5, 128.7, 123.7, 123.3, 120.5, 115.5, 104.0, 98.7, 93.7, 83.2, 83.0, 75.3. HR-ESI-MS m/z: found 477.0950, calculated 477.0941 [M+Na]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
8.1% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5.3% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5.6% | With potassium carbonate In 1,4-dioxane at 80℃; | 5.1.3 General procedure for the synthesis of compounds 4 and 8 General procedure: Target compounds 4 and 8 were semi-synthesized from kaempferol with α- bromine substituted ketos using an etherification reaction. A solution of the bromine substituted ketos (1.0eq) in 1,4-dioxane (5ml) was added to a mixture of kaempferol (1.2eq) and K2CO3 (1.2eq) in 1,4-dioxane (10ml; stirred for 90min while maintaining gentle reflux) and mixed for 30min. Stirring of the reaction mixture at 80°C was continued until TLC indicated that the starting material had disappeared (CH2Cl2: MeOH, 95:5). Under reduced pressure, the solvent was removed from the reaction mixture, water was added, 1M HCl was added to the aqueous phase for neutralization (to pH 7), and the reaction was extracted using ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated. Gel-permeation chromatography (HW-40; CH2Cl2: MeOH, 1:1) and preparative-TLC were used to purify the crude product, which appeared as a yellow solid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42.02% | With triethylamine In tetrahydrofuran at 0 - 50℃; for 5h; Inert atmosphere; | 1 Compound 1 98: 4-[3,5,7-tris(butanoyloxy)-4-oxo-4H-chromen-2-yl]phenyl butanoate To a mixture of 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one(500 mg,1 .75 mmol,1 eq), TEA (883.80 mg, 8.73 mmol,1 .22 mL, 5 eq) in THF (20 mL) was added butanoyl chloride (930.62 mg, 8.73 mmol,912.37 uL, 5 eq) slowly at 0 °C. And then the mixture was stirred at 50 °C for 5 hr under N atmosphere. LC-MS showed reactant was consumed completely and one main peak with desired mass was detected. The reaction mixture was quenched by addition H O 200 mL at 25 °C and then extracted with EtOAc 180 mL (60 mL * 3). The combined organic layers were washed with brine 20 mL, dried over Na2SC>4, filtered and concentrated under reduced pressure to give a residue. The residue was purified by column chromatography (S O , Petroleum ether/Ethyl acetate=5/1 to 3:1 ). [4-[3,5,7-tri(butane- yloxy)-4- oxo-chromen-2-yl]phenyl]butanoate (437 mg, 734.02 umol,42.02% yield,95.17% purity) was obtained as a white solid. LCMS: (M+H+) 567.2 1 .577 min; LCMS: (M+H+) 567.2 3.520 min. NMR (400 MHz, Chloroform-d) d 12.10 (s,1 H), 7.88 - 7.58 (m, 2H), 7.36 (d, J = 8.3 Hz,1 H),6.86 (d, J = 2.0 Hz,1 H),6.59 (d, J = 2.0 Hz,1 H), 2.87 - 2.37 (m, 8H),1 .41 - 1 .12 (m,12H) |
42.02% | With triethylamine In tetrahydrofuran at 0 - 50℃; for 5h; Inert atmosphere; | Compound 166: 4-[3,5,7-tris(butanoyloxy)-4-oxo-4H-chromen-2-yl]phenyl butanoate To a mixture of 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one (500 mg, 1 .75 mmol, 1 eg), TEA (883.80 mg, 8.73 mmol, 1 .22 ml_, 5 eg) in THF (20 ml_) was added butanoyl chloride (930.62 mg, 8.73 mmol, 912.37 uL, 5 eg) slowly at 0 C. And then the mixture was stirred at 50 C for 5 hr under N2 atmosphere. LC-MS showed reactant was consumed completely and one main peak with desired mass was detected. The reaction mixture was quenched by addition H2O 200 ml_ at 25 C and then extracted with EtOAc 180 ml_ (60 ml_ * 3). The combined organic layers were washed with brine 20 ml_, dried over Na2SC>4, filtered and concentrated under reduced pressure to give a residue. The residue was purified by column chromatography (S1O2, Petroleum ether/Ethyl acetate=5/1 to 3:1 ). [4-[3,5,7-tri(butane-yloxy)-4- oxo-chromen-2-yl]phenyl]butanoate (437 mg, 734.02 umol, 42.02% yield, 95.17% purity) was obtained as a white solid. LCMS: (M+H+) 567.2 at 1 .577 min; LCMS: (M+H+) 567.2 at 3.520 min. 1H NMR (400 MHz, Chloroform-d) d 12.10 (s, 1H), 7.88 - 7.58 (m, 2H), 7.36 (d, J = 8.3 Hz, 1H), 6.86 (d, J = 2.0 Hz, 1H), 6.59 (d, J = 2.0 Hz, 1H), 2.87 -2.37 (m, 8H), 1 .41- 1 .12 (m, 12H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
34.6% | With potassium carbonate In 1,4-dioxane at 80℃; for 24h; | General procedure for compounds C1 and C2 General procedure: A mixture of kaempferol (175 mg, 0.61 mmol), 4-cyanobenzyl bromide (100 mg, 0.51 mmol) or 4-(2-bromoacetyl)benzonitrile (114 mg, 0.51 mmol), and K2CO3 (84 mg, 0.61 mmol) in 1,4-dioxane (10 mL) was heated at 80 °C for 24 h. The mixture was cooled, filtered, concentrated, and purified on gel column chromatography to give a yellow solid C1 or C2. 4-(((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl) oxy)methyl)benzonitrile (C1), yellow solid; Yield, 34.6%; 1H NMR (400 MHz, DMSO-d6) δ: 12.63 (s, 1H, OH), 10.88 (s, 1H, OH), 10.24 (s, 1H, OH), 7.85 (d, J = 8.8 Hz, 2H), 7.79 (d, J = 8.4 Hz, 2H), 7.59 (d, J = 8.4 Hz, 2H), 6.88 (d, J = 8.8 Hz, 2H), 6.44 (d, J = 2.0 Hz, 1H), 6.22 (d, J=2.0 Hz, 1H), 5.10 (s, 2H); 13C NMR (100 MHz, DMSO-d6) δ: 177.7, 164.2, 161.2, 160.2, 156.5, 156.4, 142.3, 136.1, 132.1, 130.3, 128.6, 120.4, 118.7, 115.5, 110.6, 104.2, 98.7, 93.8, 72.4; HR-ESIMS (m/z): [M + Na]+ calcd. for C23H15NNaO6: 424.0797, found: 424.0795. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
37.5% | With potassium carbonate In 1,4-dioxane at 80℃; for 24h; | General procedure for compounds C1 and C2 General procedure: A mixture of kaempferol (175 mg, 0.61 mmol), 4-cyanobenzyl bromide (100 mg, 0.51 mmol) or 4-(2-bromoacetyl)benzonitrile (114 mg, 0.51 mmol), and K2CO3 (84 mg, 0.61 mmol) in 1,4-dioxane (10 mL) was heated at 80 °C for 24 h. The mixture was cooled, filtered, concentrated, and purified on gel column chromatography to give a yellow solid C1 or C2. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | Stage #1: kaempferol With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5h; Stage #2: 1-iodo-propane In N,N-dimethyl-formamide at 20℃; for 10h; | Preparation of Compound 1 Dissolve kaempferol (100 mg, 0.349 mmol) in DMF (15 mL),Then potassium carbonate (120 mg, 0.873 mmol) was added.After the mixture was stirred at room temperature for 0.5 hours,1-Iodopropane (70.4 μL, 0.722 mmol) was added and stirred at room temperature for 10 hours.After the reaction was completed, the reaction mixture was diluted with ethyl acetate and extracted twice with water. The organic phase was concentrated under vacuum. The crude product was purified by silica gel chromatography (petroleum ether / ethyl acetate, 3: 1, v / v) to give compound 1 as a yellow solid (56.5 mg, 45%). |
45% | Stage #1: kaempferol With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5h; Stage #2: 1-iodo-propane In N,N-dimethyl-formamide at 20℃; for 10h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | Stage #1: kaempferol With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5h; Stage #2: prenyl bromide In N,N-dimethyl-formamide at 65℃; for 1.5h; | Preparation of Compound 5 Dissolve kaempferol (200mg, 0.699mmol) in DMF (15mL),Then potassium carbonate (483 mg, 3.49 mmol) was added.After the mixture was stirred at room temperature for 0.5 hours,Add 1-bromo-3-methyl-2-butene (170 μL, 1.47 mmol),It was stirred at 65 ° C for 1.5 hours. After the reaction was completed, the reaction mixture was diluted with ethyl acetate and extracted twice with water. The organic phase was concentrated under vacuum. The crude product was purified by silica gel chromatography (petroleum ether / ethyl acetate, 4: 1, v / v) to obtain compound 5 as a pale yellow solid (142.9 mg, 50%). |
50% | Stage #1: kaempferol With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5h; Stage #2: prenyl bromide In N,N-dimethyl-formamide at 50℃; for 1.5h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
19.86% | With triethylamine In dichloromethane at 15℃; for 12h; | 1 To a solution of 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one (100 mg, 349 36 pmol, 1 eq) in DCM (5 ml_) was added EbN (176.76 mg, 1.75 mmol, 243.14 pL, 5 equiv.) and methyl (E)-4-chloro-4- oxo-but-2-enoate (260 mg, 1.75 mmol, 5 equiv.). The mixture was stirred at 15 °C for 12 h. LC-MS showed the desired compound was detected. The reaction mixture was concentrated under reduced pressure to give a residue. The residue was purified by prep-HPLC (water + 0.05% (v/v) HCI / ACN).The title compound was obtained as a white solid (52 mg, 69.37 pmol, 19.86% yield, 98% purity). LCMS (M+H)+: 735.2. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
19.15% | With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran at 15℃; for 12h; | 1 Compound 56: 04-[4-[3-hydroxy-5,7-bis[[(E)-4-methoxy-4-oxo-but-2-enoyl]oxy]-4-oxo-chromen-2- yl]phenyl] 01-methyl (E)-but-2-enedioate To a solution of 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one (0.2 g, 698.72 mhioI, 1 equiv.) and (E)-4-methoxy-4-oxo-but-2-enoic acid (545.42 mg, 4.19 mmol, 6 equiv.) in THF (5 ml) was added DCC (720.83 mg, 3.49 mmol, 706.69 mI-, 5 equiv.) and DMAP (4.27 mg, 34.94 pmol, 0.05 equiv.). The mixture was stirred at 15 °C for 12 h. LCMS detected the desired compound. The mixture was filtered and concentrated under reduced pressure to give a residue. The residue was purified by prep- HPLC (water + 0.05% (v/v) HCI / ACN) to afford the title compound as a yellow solid (40 mg, 133.82 mitioI, 19.15% yield, 98% purity). LCMS (M+H)+: 623.1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1: 62% 2: 12% | With potassium carbonate In acetone at 20℃; for 1h; | 4.5 Semisynthesis of compounds 2, 4-5, 9-10, 16-19, 22, 28 and 29 General procedure: Semisynthesis of compound 8 from 7; 13 and 14 from 12; 32 and 33 from 31 were previously reported, using dimethyl sulfate (Me2SO4, 4 equiv.) and 1,8-diazobicyclo[5.4.0]undec-7-en (DBU, 2 equiv.) in dried acetone at room temperature [12]. Methylation of isolated compounds 20 and 27 to provide 22, 28 and 29 and methylation of commercially available compounds 1, 3, 6 and 15 to provide compounds 2, 4-5, 9-10, 16-19, respectively, were performed by stirring the substrate with methyl iodide (MeI, 13.5 equiv.) and potassium carbonate (K2CO3, 6.6 equiv.) in dried acetone at room temperature for 1h. The crude reaction mixtures were precipitated and washed with ice-cold water. The resulting residues were solubilized with EtOAc (10mL) and treated with 1N HCl solution (3mL). The final products were extracted with EtOAc (3x10 mL) and the organic phases were washed with saturated NaCl solution and dried over Na2SO4. After filtration, and solvent evaporation, methylated compounds were purified by silica gel chromatography, using a mixture of CH2Cl2/MeOH (99.1/0.1 to 95/5 v/v) as eluent. Identification of resulting pure compounds was confirmed by comparison of 1H, 13C NMR and MS analysis with literature data. Methylation of 50mg (0.20mmol) of 5,7-dihydroxyflavone (chrysin, 1) afforded 2 (48.5mg, yield 92%) [28]. Methylation of 50mg (0.19mmol) of 5,7,4′-trihydroxyflavone (apigenin, 3) gave 4 (31.6mg, 60%) and 5 (8.3mg, 15%) with a ratio of 4/1 [29]. Methylation of 100mg (0.35mmol) of 5,7,3′,4′-tetrahydroxyflavone (kaempferol, 6) gave 9 (71.1mg, 62%) and 10 (14.3mg, 12%) with a ratio of 5/1 [30]. Methylation of 150mg (0.5mmol) of 3,5,7,3′,4′-pentahydroxyflavone (quercetin, 15) gave 16 (15.6mg, 10%), 17 (15.6mg, 9.5%), 18 (97.8mg, 55%) and 19 (17.0, 9.2%) with a ratio of 1/1/6/1 [31-33]. Methylation of 6mg (0.017mmol) of 20 gave 22 (5.5mg, 85%) [34]. Methylation of 12mg (0.032mmol) of 27 gave 28 (7.5mg, 61%) and 29 (3.9mg, 28%) with a ratio of 2/1 [35]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83.3% | In ethanol at 20℃; for 24h; | |
83.3% | In ethanol at 20℃; for 5h; | 1-8 Example 1 Weigh 1.30 g of 5-fluorouracil and 2.86 g of kaempferol, add 30 ml of absolute ethanol to obtain a suspension, place the suspension at room temperature and stir for 5 hours. After filtration, the obtained white solid was dried at 40°C to obtain a solid sample of co-crystal of 5-fluorouracil and kaempferol with a yield of 83.3%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With α-glucosidase from sulfolobus solfataricus; In dimethyl sulfoxide; at 45℃; for 2h;pH 9.0;Enzymatic reaction; | General procedure: A mixture of donor sugar (1, 0.12mmol) and acceptor (0.1mmol) in Tris-HCl buffer (5mL; 0.2M; pH 9.0) containing 30% DMSO was treated with MalA-D416A (1mg), and the mixture was incubated for 2h at 45C. The flavonoid glucosides were purified on a C18 SEP PAK cartridge (Waters) to remove unreacted sugar, DMSO, proteins and salts. After the solvent was evaporated under reduced pressure, transfer products were isolated by flash silica gel chromatography by solvent gradient elution (ethyl acetate/methanol/water, 17:2:1 to 7:2:1). The structures of purified product were characterized by LC-MS, 1D (1H and 13C) and 2D (COSY, HSQC, HMBC, and NOESY) NMR spectra, successively. The isolation yield of each transfer product was calculated using the weight of the isolated product based on the subjected flavonoid as the substrate. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: kaempferol With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5h; Stage #2: 1,4-dibromo-butane In N,N-dimethyl-formamide at 120℃; for 2h; | Synthesis of the Title Compound 2e The mixture of kaempferol (1 mmol, 286 mg) and K2CO3 (1 g) was stirred in anhydrous DMF (10 mL) at room temperature for 30 min. 1,4-dibromobutane (2 mmol, 240 µL) in anhydrous DMF (5 mL) was added dropwise to the mixture solution, which was heated to 120 °C for 2 h. After completion of the reaction monitored by TLC, the reaction mixture was cooled and extracted by ethyl acetate (3×10 mL). The organic phase was dried over MgSO4 and purified by flash chromatography with methyl alcohol/dichloromethane (1 : 10, v/v) to give the intermediate compound 2e-1. In the next step, compound 2e-1 in anhydrous CH3CN (10 mL) was added dropwise to the mixture of berberrubine (1.2 mmol, 386 mg) and K2CO3 (1 g) in anhydrous CH3CN (10 mL) at 0 °C, and then heated to 50-60 °C overnight. The reaction mixture was cooled and filtered. The filter cake was purified by flash chromatography with methyl alcohol/dichloromethane (1:20-1:30, v/v) to give the target compound 2e. The yield was 47%. 7-(4-Bromobutoxy)-3,5-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one (2e-1). A yellow solid was obtained. ESIMS m/z: 419.00 (M-H)+. 1H-NMR (600 MHz, DMSO-d6) δ: 12.46 (s, 1H), 10.13 (s, 1H), 9.52 (s, 1H), 8.08 (d, J=8.9 Hz, 2H), 6.93 (d, J=8.9 Hz, 2H), 6.74 (d, J=2.1 Hz, 1H), 6.34 (d, J=2.1 Hz, 1H), 4.13 (t, J=6.4 Hz, 2H), 3.62 (t, J=6.7 Hz, 2H), 1.97 (dt, J=14.5, 6.7 Hz, 2H), 1.86 (dt, J=13.2, 6.5 Hz, 2H). Purity by anal. HPLC: 96% (254 nm). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride In methanol at 80℃; for 4h; | 3.6. Acid Hydrolysis of Compounds 4-8 General procedure: 5 mg of each compound was separately refluxed with 2M HCl in MeOH (5 mL) at80 C for 4 h in a water bath. The reaction mixture was evaporated, and the hydrolysateafter dilution with H2O (10 mL) was extracted with CHCl3 (3 10 mL). The CHCl3 extractswere evaporated to afford the aglycones, which were identified as kampferol for 4 and 7,isorhamnetin for 5, quercetin for 6 and benzyl alcohol for 8 by comparison with authenticsamples, respectively. The aqueous layer was neutralized with sodium carbonate andconcentrated to 1 mL under reduced pressure. The residue was compared with standardsugars by Si gel TLC [(CHCl3-MeOH-H2O:30:12:4), 9 mL of lower layer and 1 mL ofHOAc], which indicated the sugars to be L-rhamnose in compounds 4, 6 and 7 and glucosein compounds 5 and 8. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; dicyclohexyl-carbodiimide In chloroform at 60℃; for 4h; | 1 Example 1 The Aβ inhibitor kaempferol (0.3 mmol), DCC (0.02 mmol), and DMAP (0.02 mmol) were dissolved in 5 ml of chloroform, and the linker dithiodipropionic acid (0.3 mmol) containing disulfide bonds was added, and stirred at 60 °C for 4 h , the solvent was removed by rotary evaporation under vacuum at 30°C, and the solid product K-LSS was obtained by separating and purifying with a chromatographic column. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
6% | With aluminum oxide In 1,2-dichloro-ethane at 140℃; for 2h; | 8 Synthesis of 1-152: macarangin (6-geranyl kaempferol) 52 mg (1.0 equiv.) of kaempferol and 30 mg (1.0 equiv.) of geraniol (3,7- dimethylocta-trans-2,6-dien-1-ol) were suspended in dichloroethane. 2.0 g/mmol of dry acidic alumina (AI203) relative to the scaffold was added to the reaction mixture, which was subsequently heated at 140°C for 2 hours in a monowave reactor. The mixture was then poured over diatomaceous earth and washed with ethyl acetate. The collected solvents were combined and concentrated under reduced pressure. Macarangin (6- geranylkaempferol was eluted through column chromatography on a C18 column using water/acetonitrile (0.1% trifluoroacetic acid) (3.6 mg, 6 % yield). 1H NMR (400 MHz, Chloroform-d) d 11.73 (s, 1H), 8.13 (d, J = 8.9 Hz, 2H), 6.98 (d, J = 8.9 Hz, 2H), 6.59 (s, 1 H), 6.33 (s, 1 H), 6.04 (s, 1H), 5.31 (td, J = 7.1 , 1.3 Hz, 1H), 5.09 (s, 1H), 5.04 (dddd, J =8.1 , 6.6, 2.9, 1.4 Hz, 1H), 3.71 (s, 1H), 3.63 (d, J = 7.1 Hz, 2H), 2.10 (m, 4H), 1.86 (s, 3H), 1.66 (s, 3H), 1.58 (s, 3H). |
Tags: 520-18-3 synthesis path| 520-18-3 SDS| 520-18-3 COA| 520-18-3 purity| 520-18-3 application| 520-18-3 NMR| 520-18-3 COA| 520-18-3 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :